Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Jan 7, 2028 (in 450 days)
Similar opportunities open now
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Sep 2028
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Nov 18, 2026 (in 35 days)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Sep 2027
Classification and identifiers
- Solicitation number
- PAR-25-321
- Assistance listing (CFDA)
- 93.394
Amount
Amount not listed here. Check the official program.
Who can apply
State government agencies and Local government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.